Bausch + Lomb addresses recent IOL recall, ensuring safety with enhanced protocols and returning enVista lenses to market ...

The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety concerns. The company said it was recalling several of its enVista lenses ...

Bausch + Lomb (BLCO) stock gains as the company plans to relaunch enVista lenses after addressing health concerns which led ...

Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the voluntary recall of intraocular lenses on its enVista platform. The recall ...

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...

Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb has received reports of toxic anterior segment syndrome in patients with enVista IOLs.